Bo Wen

Bo Wen

Digital Health, IBM Research - Thomas J. Watson Research Center, Yorktown Heights, USA
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018
Verified
Conference Paper
Closed access
JKJohn U. Knickerbocker
John U. Knickerbocker
RBR. Budd
R. Budd
BDB. Dang
B. Dang
QCQ. Chen
Q. Chen
ECE. Colgan
E. Colgan
BWBo Wen
Bo Wen
Innovations in healthcare, diagnostics, sensors and data analysis with Artificial Intelligence (AI) learning / recommendations offer opportunities for improved personalized healthcare, lower costs and benefits to the medical industry. The age of personalized human health monitoring has begun. Human health monitoring using fluidic diagnostic monitoring, non-invasive sensors, wearables (electronic health sensors), implanted health sensors, sound, visual images, and combinations of these data trends offer individuals personalized healthcare guidance. The data, analytics and recommendations from these personalized solutions are beginning to aide our early detection and understanding of health risks from chronic diseases and overall health / wellness. Examples include: cardiovascular disease, diabetes, oncology / cancer, kidney disease, elder care, Parkinson / Huntington Diseases, and many other healthcare applications. Rapid advancements of innovative healthcare diagnostic tools, health and environmental sensors along with data trending and analysis using AI systems or platforms can provide industry disruptions in healthcare. AI systems already aid health professionals and individuals with knowledge and recommendations that offer the promise of improved quality of life and lower healthcare costs. Examples such as: (1) earlier chronic disease detection and potential for disease progression delay or prevention, (2) understanding individual behavior, medication treatments and effectiveness of the treatments on activities of daily living and (3) personalized care based on your DNA, medical diagnostics and your healthcare trends relative to your healthcare needs and options to manage your quality of life. In this paper, we describe both new technologies and advancements to heterogeneous integration technology tools, materials and processes that provide differentiating electronics for future healthcare diagnostic tools and sensors. These new technologies are being applied to targeted applications in healthcare diagnostics and sensor monitoring for precision diagnostic data, smaller product size and much lower costs. Data streams can leverage AI to provide smart personalized healthcare guidance or solutions that compliment existing technology and data to partners such as healthcare professionals, patients and clients. In many applications, we leverage industry available technology or benefit from these new technology advancements to provide for the best system solution. Examples of these new and advancing technologies include: (1) Precision handling thinned wafers with large die, small die, multi-die, sub-components, components and substrates technologies, (2) Injection molded solder (IMS) technology for wafers (TSV and / or interconnection) and substrates, (3) Precision micro-component, die, multi-die substrate and multi-component assembly / integration technology for healthcare, IoT and AI Systems, (4) Precision laser micro-machining, cutting and welding technology, (5) Flexible multi-channel, micro-fluidic systems for smart sensing, point of care (POC) diagnostics, and AI and (6) Small form factor micro-systems and energy solutions / technologies that support future healthcare, IoT, and AI linked computing solutions. Examples of key challenges and advantages of these technologies for the targeted applications are shared relative to current industry standard solutions. Highlights on future demonstrations in progress at the time of writing this paper are targeted for our 2018 ECTC presentation and other future technical publications.

16 May 2024 in JMIR Mental Health
Verified
Journal Article
Open access
BBBrian Bauer
Brian Bauer
RNRaquel Norel
Raquel Norel
ALAlex Leow
Alex Leow
ZRZad Abi Rached
Zad Abi Rached
BWBo Wen
Bo Wen
GCGuillermo Cecchi
Guillermo Cecchi
Background: Rates of suicide have increased by over 35% since 1999. Despite concerted efforts, our ability to predict, explain, or treat suicide risk has not significantly improved over the past 50 years. Objective: The aim of this study was to use large language models to understand natural language use during public web-based discussions (on Reddit) around topics related to suicidality. Methods: We used large language model–based sentence embedding to extract the latent linguistic dimensions of user postings derived from several mental health–related subreddits, with a focus on suicidality. We then applied dimensionality reduction to these sentence embeddings, allowing them to be summarized and visualized in a lower-dimensional Euclidean space for further downstream analyses. We analyzed 2.9 million posts extracted from 30 subreddits, including r/SuicideWatch, between October 1 and December 31, 2022, and the same period in 2010. Results: Our results showed that, in line with existing theories of suicide, posters in the suicidality community (r/SuicideWatch) predominantly wrote about feelings of disconnection, burdensomeness, hopeless, desperation, resignation, and trauma. Further, we identified distinct latent linguistic dimensions (well-being, seeking support, and severity of distress) among all mental health subreddits, and many of the resulting subreddit clusters were in line with a statistically driven diagnostic classification system—namely, the Hierarchical Taxonomy of Psychopathology (HiTOP)—by mapping onto the proposed superspectra. Conclusions: Overall, our findings provide data-driven support for several language-based theories of suicide, as well as dimensional classification systems for mental health disorders. Ultimately, this novel combination of natural language processing techniques can assist researchers in gaining deeper insights about emotions and experiences shared on the web and may aid in the validation and refutation of different mental health theories.

1 July 2022
Verified
Conference Paper
Closed access
BWBo Wen
Bo Wen
Vince SiuVince Siu
Vince Siu
IBItalo Buleje
Italo Buleje
KHKuan Yu Hsieh
Kuan Yu Hsieh
TITakashi Itoh
Takashi Itoh
JRJeffrey L. Rogers
Jeffrey L. Rogers
This paper highlights the design philosophy and architecture of the Health Guardian, a platform developed by the IBM Digital Health team to accelerate discoveries of new digital biomarkers and development of digital health technologies. The Health Guardian allows for rapid translation of artificial intelligence (AI) research into cloud-based microservices that can be tested with data from clinical cohorts to understand disease and enable early prevention. The platform can be connected to mobile applications, wearables, or Internet of things (IoT) devices to collect health-related data into a secure database. When the analytics are created, the researchers can containerize and deploy their code on the cloud using pre-defined templates, and validate the models using the data collected from one or more sensing devices. The Health Guardian platform currently supports time-series, text, audio, and video inputs with 70+ analytic capabilities and is used for non-commercial scientific research. We provide an example of the Alzheimer's disease (AD) assessment microservice which uses AI methods to extract linguistic features from audio recordings to evaluate an individual's mini-mental state, the likelihood of having AD, and to predict the onset of AD before turning the age of 85. Today, IBM research teams across the globe use the Health Guardian internally as a test bed for early-stage research ideas, and externally with collaborators to support and enhance AI model development and clinical study efforts.

30 January 2024 in Biosensors
Verified
Journal Article
Open access
PDF file
Vince SiuVince Siu
Vince Siu
MLMinhua Lu
Minhua Lu
KHKuan Yu Hsieh
Kuan Yu Hsieh
BWBo Wen
Bo Wen
IBItalo Buleje
Italo Buleje
RBRussell Budd
Russell Budd
This paper presents a cost-effective, quantitative, point-of-care solution for urinalysis screening, specifically targeting nitrite, protein, creatinine, and pH in urine samples. Detecting nitrite is crucial for the early identification of urinary tract infections (UTIs), while regularly measuring urinary protein-to-creatinine (UPC) ratios aids in managing kidney health. To address these needs, we developed a portable, transmission-based colorimeter using readily available components, controllable via a smartphone application through Bluetooth. Multiple colorimetric detection strategies for each analyte were identified and tested for sensitivity, specificity, and stability in a salt buffer, artificial urine, and human urine. The colorimeter successfully detected all analytes within their clinically relevant ranges: nitrite (6.25–200 µM), protein (2–1024 mg/dL), creatinine (2–1024 mg/dL), and pH (5.0–8.0). The introduction of quantitative protein and creatinine detection, and a calculated urinary protein-to-creatinine (UPC) ratio at the point-of-care, represents a significant advancement, allowing patients with proteinuria to monitor their condition without frequent lab visits. Furthermore, the colorimeter provides versatile data storage options, facilitating local storage on mobile devices or in the cloud. The paper further details the setup of the colorimeter’s secure connection to a cloud-based environment, and the visualization of time-series analyte measurements in a web-based dashboard.

16 December 2025 in JMIR AI
Verified
Journal Article
Open access
YCYuhao Chen
Yuhao Chen
BWBo Wen
Bo Wen
FZFarhana Zulkernine
Farhana Zulkernine
Background: Although large language models (LLMs) show great promise in processing medical text, they are prone to generating incorrect information, commonly referred to as hallucinations. These inaccuracies present a significant risk for clinical applications where precision is critical. Additionally, relying on human experts to review LLM-generated content to ensure accuracy is costly and time-consuming, which sets a barrier against large-scale deployment of LLMs in health care settings. Objective: The primary objective of this study was to develop an automatic artificial intelligence (AI) system capable of extracting structured information from unstructured medical data and using advanced reasoning techniques to support reliable clinical decision making. A key aspect of this objective is ensuring that the system incorporates self-verification mechanisms, enabling it to assess the accuracy and reliability of its own outputs. By integrating such mechanisms, we aim to enhance the system’s robustness, reduce reliance on human intervention, and improve the overall trustworthiness of AI-driven medical summarization and evaluation. Methods: The proposed framework comprises 2 layers: a summarization layer and an evaluation layer. The summarization layer uses Llama2-70B (Meta AI) and Mistral-7B (Mistral AI) models to generate concise summaries from unstructured medical data, focusing on tasks such as consumer health question summarization, biomedical answer summarization, and dialog summarization. The evaluation layer uses GPT-4-turbo (OpenAI) as a judge, leveraging pairwise comparison strategies and different prompt strategies to evaluate summaries across 4 dimensions: coherence, consistency, fluency, and relevance. To validate the framework, we compare the judgments generated by the LLM assistants in the evaluation layer with those provided by medical experts, offering valuable insights into the alignment and reliability of AI-driven evaluations within the medical domain. We also explore a way to handle disagreement among human experts and discuss our methodology in addressing diversity in human perspectives. Results: The study found variability in expert consensus, with average agreement rates of 19.2% among all experts and 54% among groups of 3 experts. GPT-4 (OpenAI) demonstrated alignment with expert judgments, achieving an average agreement rate of 83.06% with at least 1 expert and comparable performance in cross-validation tests. The enhanced guidance in prompt design (prompt-enhanced guidance) improved GPT-4’s alignment with expert evaluations compared with a baseline prompt, highlighting the importance of effective prompt engineering in auto-evaluation of summarization tasks. We also evaluated open-source LLMs, including Llama-3.3 (Meta AI) and Mixtral-Large (Mistral AI), and a domain-specific LLM, OpenBioLLM (Aaditya Ura), for comparison as LLM judges. Conclusions: This study highlights the potential of LLMs as reliable tools for unstructured medical data summarization and evaluation to reduce the dependency on human experts and also states the limitations. The proposed framework, multiagent summarization and auto-evaluation, demonstrates scalability and adaptability for clinical applications while addressing key challenges like hallucination and position bias.

10 November 2022 in arXiv
Verified
Preprint
Open access
PDF file
BWBo Wen
Bo Wen
Vince SiuVince Siu
Vince Siu
IBItalo Buleje
Italo Buleje
KHKuan Yu Hsieh
Kuan Yu Hsieh
TITakashi Itoh
Takashi Itoh
JRJeffrey L. Rogers
Jeffrey L. Rogers
This paper highlights the design philosophy and architecture of the Health Guardian, a platform developed by the IBM Digital Health team to accelerate discoveries of new digital biomarkers and development of digital health technologies. The Health Guardian allows for rapid translation of artificial intelligence (AI) research into cloud-based microservices that can be tested with data from clinical cohorts to understand disease and enable early prevention. The platform can be connected to mobile applications, wearables, or Internet of things (IoT) devices to collect health-related data into a secure database. When the analytics are created, the researchers can containerize and deploy their code on the cloud using pre-defined templates, and validate the models using the data collected from one or more sensing devices. The Health Guardian platform currently supports time-series, text, audio, and video inputs with 70+ analytic capabilities and is used for non-commercial scientific research. We provide an example of the Alzheimer's disease (AD) assessment microservice which uses AI methods to extract linguistic features from audio recordings to evaluate an individual's mini-mental state, the likelihood of having AD, and to predict the onset of AD before turning the age of 85. Today, IBM research teams across the globe use the Health Guardian internally as a test bed for early-stage research ideas, and externally with collaborators to support and enhance AI model development and clinical study efforts.